Your browser doesn't support javascript.
loading
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity.
Farina, Antonio; Birzu, Cristina; Elsensohn, Mad-Hélénie; Picca, Alberto; Muñiz-Castrillo, Sergio; Vogrig, Alberto; Villagrán-García, Macarena; Ciano-Petersen, Nicolás Lundahl; Massacesi, Luca; Hervier, Baptiste; Guégan, Sarah; Kramkimel, Nora; Vano, Yann; Salem, Joe Elie; Allenbach, Yves; Maisonobe, Thierry; Assaad, Souad; Maureille, Aurélien; Devic, Perrine; Weiss, Nicolas; Pegat, Antoine; Maucort-Boulch, Delphine; Ricard, Damien; Honnorat, Jérôme; Psimaras, Dimitri; Joubert, Bastien.
Afiliación
  • Farina A; Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Neurological Hospital, Bron 69677, France.
  • Birzu C; MeLiS - UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon 69008, France.
  • Elsensohn MH; Department of Neuroscience, Psychology, Pharmacology and Child Health, University of Florence, Florence 50139, Italy.
  • Picca A; Department of Neurology 2 Mazarin, Sorbonne University, Brain Institute, INSERM UMR 1127, Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France.
  • Muñiz-Castrillo S; OncoNeuroTox Group, Center for Patients with Neurological Complications of Oncologic Treatments Groupe Hospitalier Pitié-Salpêtrière et Hôpital Percy, Paris 75561, France.
  • Vogrig A; Biostatistics-Bioinformatics Department, Public Health Unit. Hospices Civils de Lyon, Lyon 69003, France.
  • Villagrán-García M; Laboratory of Biometry and Evolutionary Biology, University Claude Bernard Lyon 1, Villeurbanne 69622, France.
  • Ciano-Petersen NL; CNRS, UMR5558, Laboratory of Biometry and Evolutionary Biology, Biostatistics-Health Team, Villeurbanne 69622, France.
  • Massacesi L; Department of Neurology 2 Mazarin, Sorbonne University, Brain Institute, INSERM UMR 1127, Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France.
  • Hervier B; OncoNeuroTox Group, Center for Patients with Neurological Complications of Oncologic Treatments Groupe Hospitalier Pitié-Salpêtrière et Hôpital Percy, Paris 75561, France.
  • Guégan S; Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Neurological Hospital, Bron 69677, France.
  • Kramkimel N; MeLiS - UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon 69008, France.
  • Vano Y; Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Neurological Hospital, Bron 69677, France.
  • Salem JE; MeLiS - UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon 69008, France.
  • Allenbach Y; Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Neurological Hospital, Bron 69677, France.
  • Maisonobe T; MeLiS - UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon 69008, France.
  • Assaad S; Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Neurological Hospital, Bron 69677, France.
  • Maureille A; MeLiS - UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon 69008, France.
  • Devic P; Department of Neuroscience, Psychology, Pharmacology and Child Health, University of Florence, Florence 50139, Italy.
  • Weiss N; Department of Internal Medicine, AP-HP, Hôpital St Louis, Paris 75010, France.
  • Pegat A; Department of Dermatology, AP-HP, Hôpital Cochin, Paris 75014, France.
  • Maucort-Boulch D; Department of Dermatology, Université de Paris Cité, Paris 75006, France.
  • Ricard D; Department of Dermatology, AP-HP, Hôpital Cochin, Paris 75014, France.
  • Honnorat J; Department of Medical Oncology, AP-HP, Centre Hôpital Européen Georges-Pompidou, Paris 75015, France.
  • Psimaras D; Department of Pharmacology, Sorbonne University, INSERM, UNICO-GRECO Cardio-oncology Program, CIC-1901, AP-HP, Hôpital Pitié-Salpêtrière, F-75013 Paris, France.
  • Joubert B; APHP, Department of Internal Medicine, Sorbonne University, Sorbonne University, INSERM Groupe Hospitalier Pitié-Salpêtrière, Paris 75651, France.
Brain Commun ; 5(3): fcad169, 2023.
Article en En | MEDLINE | ID: mdl-37389303
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Brain Commun Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Brain Commun Año: 2023 Tipo del documento: Article País de afiliación: Francia